Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RELA | Q04206 | 1/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.41 |
| ▸ | MAOB | P27338 | 2/20 | 0.40 |
| ▸ | MAOA | P21397 | 1/20 | 0.40 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.37 |
| ▸ | LTA4H | P09960 | 1/20 | 0.37 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.36 |
| ▸ | RAB9A | P51151 | 2/20 | 0.36 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.36 |
| ▸ | THPO | P40225 | 1/20 | 0.36 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.36 |
| ▸ | MTOR | P42345 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.36 |
| ▸ | TSHR | P16473 | 1/20 | 0.36 |
| ▸ | TP53 | P04637 | 1/20 | 0.36 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.36 |
| ▸ | NPC1 | O15118 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28054696 | 0.87 | RELA (0.41) | RELAKMT2ARAB9ACYP1A2CYP3A4 | |
| SCHEMBL789470 | 0.82 | RELA (0.41) | RELAKMT2AMEN1NR1I2MAOB | |
| SCHEMBL815747 | 0.81 | MEN1 (0.39) | RELAKMT2AMEN1NR1I2TRPA1 | |
| SCHEMBL8340935 | 0.81 | RELA (0.40) | RELAKMT2AMEN1NR1I2MAOB | |
| SCHEMBL9798232 | 0.79 | ALDH1A1 (0.39) | RELAMAOBMAOATRPA1CYP3A4 | |
| SCHEMBL8341640 | 0.79 | RELA (0.39) | RELAKMT2AMEN1NR1I2RAB9A | |
| SCHEMBL317685 | 0.78 | LTA4H (0.47) | RELAKMT2AMEN1LTA4HCYP1A2 | |
| SCHEMBL5410674 | 0.76 | TRPA1 (0.39) | RELAKMT2AMEN1MAOBTRPA1 | |
| SCHEMBL60042 | 0.76 | RELA (0.53) | RELAKMT2AMEN1MAOBMAOA | |
| SCHEMBL17836905 | 0.76 | RELA (0.53) | RELAKMT2AMEN1MAOBMAOA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1845 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240238455-A1 | A COMPOSITE FERRITE NANOPARTICLE WITH SYNERGISTIC ENHANCEMENT OF LIVER SPECIFICITY AND PREPARATION METHOD AND APPLICATION THEREOF | XI'AN SUPERMAG BIO-NANOTECH CO., LTD. (CN) | 2024-07-18 | — | — | US | claimed |
| EP-3575281-B1 | DIAMINE COMPOUND, AND POLYIMIDE COMPOUND AND MOLDED ARTICLE IN WHICH SAID DIAMINE COMPOUND IS USED | WINGO TECH CO LTD (JP) | 2023-08-23 | — | — | EP | claimed |
| WO-2023122564-A2 | TISSUE-SPECIFIC MANGANESE BASED MRI CONTRAST AGENTS | CASE WESTERN RESERVE UNIVERSITY (US) | 2023-06-29 | — | — | WO | claimed |
| EP-4200309-A1 | STEREOSELECTIVE MANUFACTURE OF SELECTED PURINE PHOSPHORAMIDATES | ATEA Pharmaceuticals, Inc. (US) | 2023-06-28 | — | — | EP | claimed |
| CN-110272386-B | Preparation method of nodispat | 上海医药集团青岛国风药业股份有限公司 | 2022-09-09 | — | — | CN | claimed |
| WO-2022038365-A9 | FUMARATE DERIVATIVES AND THEIR MEDICAL USE | SITRYX THERAPEUTICS LIMITED (GB) | 2022-07-14 | — | — | WO | claimed |
| CN-114716386-A | Novel exosome inhibitor and preparation method thereof | 北京和理咨询有限公司 | 2022-07-08 | — | — | CN | claimed |
| WO-2022040473-A1 | STEREOSELECTIVE MANUFACTURE OF SELECTED PURINE PHOSPHORAMIDATES | Atea Pharmaceuticals, Inc. (US) | 2022-02-24 | — | — | WO | claimed |
| CN-113874375-A | Cyclic amide compounds and methods thereof for the treatment of rabies | 株式会社大分大学先端医学研究所 | 2021-12-31 | — | — | CN | claimed |
| US-11168050-B2 | Efficient synthesis of amines and amides from alcohols and aldehydes by using cascade catalysis | XP CHEMISTRIES AB (SE) | 2021-11-09 | — | — | US | claimed |
| US-4529721-A | Human and veterinary bactericide | SHIONOGI & CO., LTD. (JP) | 1985-07-16 | — | — | US | claimed |
| EP-0037082-B1 | PROCESS FOR THE PREPARATION OF 1-CARBAPENEMS AND INTERMEDIATES VIA SILYL-SUBSTITUTED DITHIOACETALS | MERCK & CO. INC. (US) | 1985-03-20 | — | — | EP | claimed |
| US-4444754-A | SYNERGISTIC WITH PENICILLIN | BEECHAM GROUP LIMITED (GB) | 1984-04-24 | — | — | US | claimed |
| US-4426389-A | BACTERICIDES, ENZYME INHIBITORS | BEECHAM GROUP LIMITED (GB) | 1984-01-17 | — | — | US | claimed |
| US-4407815-A | AMINO ACID DERIVATIVE ANTIBIOTICS | BEECHAM GROUP LIMITED (GB) | 1983-10-04 | — | — | US | claimed |
| US-4359473-A | α-Amino deoxy clavulanic acid antibacterial agents | BEECHAM GROUP LIMITED (GB) | 1982-11-16 | — | — | US | claimed |
| US-4343807-A | BETA-LACTAMASE INHIBITORS, BACTERICIDES, ANTIBIOTICS | BEECHAM GROUP LIMITED (GB) | 1982-08-10 | — | — | US | claimed |
| US-4301168-A | BACTERICIDES, BETA-LACTAMASE INHIBITORS | BEECHAM GROUP LIMITED (GB) | 1981-11-17 | — | — | US | claimed |
| EP-0005014-A1 | Clavulanic acid derivatives, preparation and compositions | BEECHAM GROUP PLC (GB) | 1979-10-31 | — | — | EP | claimed |
| US-3940395-A | CNS DEPRESSANT | AMERICAN HOME PRODUCTS CORPORATION (US) | 1976-02-24 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11168050-B2 | Efficient synthesis of amines and amides from alcohols and aldehydes by using cascade catalysis | ADH5, ADH1A, ADH1C | RELA 773/4885KMT2A 1699/4885MEN1 4401/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.